| Spirig HealthCare AG - Mometason Spirig HC Nasenspray, Suspension |
| 67641 | | 01 | | Mometason Spirig HC Nasenspray | | Suspension | | R01AD09 | | Mometason | | 14.05.2020 | | |
|
| Composition |
| mometasoni furoas 0.5 mg ut mometasoni furoas monohydricus, benzalkonii chloridum 0.2 mg, glycerolum, polysorbatum 80, cellulosum microcristallinum et carmellosum natricum, acidum citricum monohydricum, natrii citras anhydricus, aqua purificata ad suspensionem pro 1 g corresp. mometasoni furoas 50 µg pro dosi, doses pro vase 140. |
| Packungsbestandteile |
| Suspension | | | | | | | | Principe actif | Concentr. |
|---|
| Mometasoni Furoas | 0.5 mg/g |
| | BAG: Principe actif | Concentr. |
|---|
| Mometasone 17 Furoate | 0.05 mg |
| | | | Agents auxilliaires | Concentr. |
|---|
| Acide Citrique Monohydre | | | Benzalkonium Chlorure | 0.2 mg/g | | Carmellosum Natricum | | | Cellulosum Microcristallinum | | | Glycerol | | | Natrii Citras Anhydricus | | | Polysorbatum 80 | |
| |
|
|
